Drug infusion systems

SynchroMed™ III intrathecal pump

<p>SynchroMed™ III is an implantable drug delivery system that helps manage chronic pain, cancer pain, and severe spasticity.</p>

Features

SynchroMed™ III pump

This system features a refill only physician workflow for more efficient programming, additional protections for patient data through enhanced cybersecurity, and improved electronics capable of delivering firmware upgrades to implanted devices going forward.

Together, these enhancements within the SynchroMed™ III system offer an enhanced platform compared to use of the SynchroMed™ II system.

SynchroMed™ III is an implantable drug delivery system that helps manage chronic pain, cancer pain, and severe spasticity.

Allows full-body 1.5 and 3T MRI scans under specific conditions

Redesigned for peace of mind

The SynchroMed™ III implantable pump continues to provide peace of mind with proven durable design enhancements built in.‡ 

A targeted drug delivery (TDD) battery image that is highlighting the coating.

Battery coating added

An image showing the targeted drug delivery (TDD) gearwheel.

Gear wheel 3 material change

This is an image of the targeted drug delivery (TDD) feedthrough.

Feedthroughs encapsulated

An image showing the diamond-like carbon (dlc) coating for targeted drug delivery.

Diamond-like carbon (DLC) coating added

Ascenda™ catheter

  • Available in two lengths
  • Flexible construction with the ability to trim to the desired length
  • Unique four-layer construction for compression resistance
  • Sutureless connector
The Ascenda™ catheter is available in two lengths and offers flexible construction and the ability to trim to the desired length.

Compatible products

SynchroMed™ clinician programmer

The SynchroMed™ clinician programmer provides a simple, guided workflow approach to programming SynchroMed™ implantable pumps.

myPTM™ personal therapy manager

The myPTM™ personal therapy manager works with the SynchroMed™ implantable pump to help alleviate unpredictable pain by enabling on-demand intrathecal boluses.

Efficio™ management software

The Efficio™ management software is designed to simplify your pump practice by offering efficient schedule planning, simple drug tracking, historical dosing insights, and on-demand access to reports.

SynchroMed™ III is an implantable targeted drug infusion system that helps manage chronic pain, cancer pain, and severe spasticity.

Ordering information

Item number Description
8667-20 SynchroMed™ III pump with 20 mL reservoir capacities, redesigned with updated electronics and firmware to enhance cybersecurity and enable upgradability
8667-40 SynchroMed™ III pump with 40 mL reservoir capacities, redesigned with updated electronics and firmware to enhance cybersecurity and enable upgradability
CT900 Tablet with A810 software v2.x, SynchroMed™ clinician programmer with refill-only workflow that streamlines clinician programming
TH90T01 myPTM™ personal therapy manager with with A820 software v2.x, updates to clarify clinician restrictions for patient bolus activation

† MR Safety Triangle Under specific conditions. Refer to product labeling for full list of conditions: Medtronic MRI manuals.

‡ Source: TDD Product Performance Report 2022.

  1. Hamza, M et al. Prospective Study of 3-Year Follow-Up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain. Pain Medicine. (United States) 13, 1304–1313 (2012).
  2. Smith, TJ et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. Journal of Clinical Oncology. 20, 4040–4049 (2002).
  3. Rushton, DN. Upper Motor Neurone Syndrome and Spasticity: Chapter 10 Intrathecal Baclofen for the Control of Spinal and Supraspinal Spasticity. ed. Barnes, MP and Johnson, GR pages 181–192. (Cambridge University Press, 2008). doi:10.1017/cbo9780511544866.011.
  4. Deer, T et al. Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Medicine. 5, 6–13 (2004).